Reusable Duodenoscope Culture Registry
NCT04210401 is an observational study sponsored by AdventHealth. As of 21 Nov 2026, it was withdrawn. It studies Endoscopy. The registry lists an enrollment of 0 participants at 1 site in 1 country. The registry lists a start date of 1 Jul 2020 and a primary completion date of 31 Dec 2020.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04210401 |
| Status | Withdrawn |
| Study type | Observational study |
| Lead sponsor | AdventHealth |
| Enrollment | 0 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Endoscopy |
| Start | 1 Jul 2020 |
| Primary completion | 31 Dec 2020 |
| Study completion | 30 Apr 2021 |
| Last update posted | 14 Mar 2022 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Shyam Varadarajulu, MD
AdventHealth Orlando
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Center for Interventional Endoscopy
Orlando
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04210401
Each answer restates registry values shown on this page.
What is NCT04210401?
NCT04210401 is an observational study sponsored by AdventHealth. It studies Endoscopy.
Who leads NCT04210401?
The registry names Shyam Varadarajulu, MD (principal investigator, AdventHealth Orlando) as the overall official.
Where does NCT04210401 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT04210401 end?
The registry lists a primary completion date of 31 Dec 2020 and a study completion date of 30 Apr 2021. The sponsor last updated the record on 14 Mar 2022.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.